Cleared Traditional

K150378 - NICO BrainPath & Accessories, NICO BrainPath, NICO Shepherd's Hook

K150378 is an FDA 510(k) clearance for NICO BrainPath & Accessories, manufactured by Nico Corporation. The device is a Class 2 Neurology device with product code GZT cleared through the Traditional 510(k) pathway after a 119-day FDA review.

K150378 · Nico Corporation · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2015
Decision
119d
Days
Class 2
Risk

K150378 is an FDA 510(k) clearance for the NICO BrainPath & Accessories, NICO BrainPath, NICO Shepherd's Hook. Classified as Retractor, Self-retaining, For Neurosurgery (product code GZT), Class II - Special Controls.

Submitted by Nico Corporation (Indianapolis, US). The FDA issued a Cleared decision on June 12, 2015 after a review of 119 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4800 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Nico Corporation devices

FDA 510(k) Submission Details - K150378

510(k) Number K150378 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 2015
Decision Date June 12, 2015
Days to Decision 119 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
30d faster than avg
Panel avg: 149d · This submission: 119d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZT Device Classification - Class 2, Special Controls

Product Code GZT Retractor, Self-retaining, For Neurosurgery
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZT Retractor, Self-retaining, For Neurosurgery

All 33
Devices cleared under the same product code (GZT) and FDA review panel - the closest regulatory comparables to K150378.
MEDICON Spinal Spreading Systems
K161680 · Medicon EG · Mar 2017
Phantom Fukushima Neurological Holding Systems, Phantom Mastability Neurological Holding Systems
K161318 · Tedan Surgical Innovations, LLC · Mar 2017
Self-retaining Retractor
K161004 · Fetzer Medical GmbH & Co. KG · Sep 2016
BRAIN PORT
K120691 · Nico Corporation · Jun 2012
SPOTLIGHT ACCESS SYSTEM
K113273 · Johnson & Johnson · Jan 2012
SPOTLIGHT ACCESS SYSTEM
K112913 · Johnson & Johnson · Dec 2011